BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 25866575)

  • 1. Sentinel lymph node biopsy (SLNB) vs. axillary lymph node dissection (ALND) in the current surgical treatment of early stage breast cancer.
    Gherghe M; Bordea C; Blidaru A
    J Med Life; 2015; 8(2):176-80. PubMed ID: 25866575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sentinel lymph node biopsy in breast cancer patients after neoadjuvant chemotherapy.
    Reitsamer R; Peintinger F; Rettenbacher L; Prokop E
    J Surg Oncol; 2003 Oct; 84(2):63-7. PubMed ID: 14502778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is sentinel lymph node biopsy more accurate than axillary dissection for staging nodal involvement in breast cancer patients?
    Marrazzo A; Taormina P; Gebbiab V; David M; Riili I; Lo Gerfo D; Casà L; Noto A
    Chir Ital; 2007; 59(5):693-9. PubMed ID: 18019642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term morbidity of patients with early breast cancer after sentinel lymph node biopsy compared to axillary lymph node dissection.
    Schulze T; Mucke J; Markwardt J; Schlag PM; Bembenek A
    J Surg Oncol; 2006 Feb; 93(2):109-19. PubMed ID: 16425290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is there any benefit from sentinel lymph node biopsy using the combined radioisotope/dye technique in breast cancer patients with clinically negative axilla?
    Koukouraki S; Sanidas E; Askoxilakis J; Stathaki M; Charalambakis V; Daboudi M; Voutoufianaki I; Kafousi M; Stathopoulos E; Tsiftsis D; Karkavitsas N
    Nucl Med Commun; 2009 Jan; 30(1):48-53. PubMed ID: 19020472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Technical feasibility of sentinel lymph node biopsy in patients with ipsilateral breast tumor recurrence and previous axillary surgery.
    Matsumoto A; Jinno H; Nakamura T; Saito J; Takahashi M; Hayashida T; Kameyama K; Kitagawa Y
    Int J Surg; 2015 Oct; 22():28-31. PubMed ID: 26278666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Axillary lymph node recurrence after sentinel lymph node biopsy performed using a combination of indocyanine green fluorescence and the blue dye method in early breast cancer.
    Inoue T; Nishi T; Nakano Y; Nishimae A; Sawai Y; Yamasaki M; Inaji H
    Breast Cancer; 2016 Mar; 23(2):295-300. PubMed ID: 25348937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sentinel Lymph Node Biopsy Versus Axillary Dissection in Node-Negative Early-Stage Breast Cancer: 15-Year Follow-Up Update of a Randomized Clinical Trial.
    Canavese G; Bruzzi P; Catturich A; Tomei D; Carli F; Garrone E; Spinaci S; Lacopo F; Tinterri C; Dozin B
    Ann Surg Oncol; 2016 Aug; 23(8):2494-500. PubMed ID: 26975739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accuracy of sentinel node biopsy in breast cancer patients with a high prevalence of axillary metastases.
    Moghimi M; Ghoddosi I; Rahimabadi AE; Sheikhvatan M
    Scand J Surg; 2009; 98(1):30-3. PubMed ID: 19447739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A longitudinal comparison of arm morbidity in stage I-II breast cancer patients treated with sentinel lymph node biopsy, sentinel lymph node biopsy followed by completion lymph node dissection, or axillary lymph node dissection.
    Kootstra JJ; Hoekstra-Weebers JE; Rietman JS; de Vries J; Baas PC; Geertzen JH; Hoekstra HJ
    Ann Surg Oncol; 2010 Sep; 17(9):2384-94. PubMed ID: 20221902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Optimal treatment of the axilla after positive sentinel lymph node biopsy in early invasive breast cancer. Early results of the OTOASOR trial].
    Sávolt A; Musonda P; Mátrai Z; Polgár C; Rényi-Vámos F; Rubovszky G; Kovács E; Sinkovics I; Udvarhelyi N; Török K; Kásler M; Péley G
    Orv Hetil; 2013 Dec; 154(49):1934-42. PubMed ID: 24292111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Sentinel lymph node biopsy in breast cancer patients--results and experience after 500 sentinel lymph node biopsies].
    Reitsamer R; Menzel C; Peintinger F; Cimpoca W; Glück S; Sinzinger G; Rettenbacher L; Kässmann H; Hoffmann A; Prokop E; Strasser F; Kiesler J; Hutarew G; Dietze O
    Gynakol Geburtshilfliche Rundsch; 2003 Apr; 43(2):98-103. PubMed ID: 12649582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Upstaging and improved survival of early breast cancer patients after implementation of sentinel node biopsy for axillary staging.
    Vanderveen KA; Schneider PD; Khatri VP; Goodnight JE; Bold RJ
    Ann Surg Oncol; 2006 Nov; 13(11):1450-6. PubMed ID: 17009150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of the axilla in patients with breast cancer and positive sentinel lymph node biopsy: An evidence-based update in a European breast center.
    Garcia-Etienne CA; Ferrari A; Della Valle A; Lucioni M; Ferraris E; Di Giulio G; Squillace L; Bonzano E; Lasagna A; Rizzo G; Tancredi R; Scotti Foglieni A; Dionigi F; Grasso M; Arbustini E; Cavenaghi G; Pedrazzoli P; Filippi AR; Dionigi P; Sgarella A
    Eur J Surg Oncol; 2020 Jan; 46(1):15-23. PubMed ID: 31445768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A prospective feasibility study of sentinel node biopsy by modified Indigocarmine blue dye methods after neoadjuvant chemotherapy for breast cancer.
    Kida K; Ishikawa T; Yamada A; Shimizu D; Tanabe M; Sasaki T; Ichikawa Y; Endo I
    Eur J Surg Oncol; 2015 Apr; 41(4):566-70. PubMed ID: 25650249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.
    Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F
    J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sentinel lymph-node biopsy compared to axillary lymph-node dissection for axillary staging in breast cancer patients.
    Schrenk P; Shamiyeh A; Wayand W
    Eur J Surg Oncol; 2001 Jun; 27(4):378-82. PubMed ID: 11417984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trends in axillary treatment for breast cancer patients undergoing sentinel lymph node biopsy as determined by a questionnaire from the Japanese Breast Cancer Society.
    Imoto S; Yamauchi C; Komoike Y; Tsugawa K; Yotsumoto D; Wada N; Ueno T; Oba MS; Shien T; Sugae S; Tsuda H; Yoneyama K
    Breast Cancer; 2017 May; 24(3):427-432. PubMed ID: 27553957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors Predictive of Sentinel Lymph Node Involvement in Primary Breast Cancer.
    Malter W; Hellmich M; Badian M; Kirn V; Mallmann P; Krämer S
    Anticancer Res; 2018 Jun; 38(6):3657-3662. PubMed ID: 29848724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of axillary lymph node dissection after sentinel lymph node biopsy on overall survival in patients with T1 or T2 node-positive breast cancer: report from the Korean Breast Cancer Society.
    Park HS; Chae BJ; Song BJ; Jung SS; Han W; Nam SJ; Youn HJ; Ko BK; Kim DW;
    Ann Surg Oncol; 2014 Apr; 21(4):1231-6. PubMed ID: 24318094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.